The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

The RELIEF ureteral stent, the brainchild of Dr. Lee Ponksy, chairman of UH’s Urology Institute, has been cleared by the U.S.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...

A nationwide recall of enchiladas has been announced after the U.S. Food and Drug Administration (FDA) identified a potential ...

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its ...

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count ...

A Class I recall is used when "a violative product will cause serious adverse health consequences or death," according to the ...